Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Zeon Corporation (4205.T)
Tokyo, JP
Zeon Corporation, based in Tokyo, Japan, and established in 1950, operates across diverse sectors including elastomers, specialized materials, and various other ventures. Its elastomers segment encompasses the production of synthetic rubbers, including general-purpose types utilized in automotive tires, alongside specialized rubbers such as NBR and hydrogenated NBR. The company also supplies synthetic latex varieties like styrene-butadiene copolymer latex, polybutadiene, and acrylonitrile butadiene copolymer latex, which find application in areas such as paper processing, fiber treatment, adhesives, paints, and rubber gloves. Furthermore, it produces materials for adhesive tapes, hot melt adhesives, binders for road marking paints, and additives for concrete. In specialty chemicals, Zeon provides synthetic aromatic compounds for the flavor and fragrance industries, as well as cyclopentene, cyclopentanone, and their derivatives for chemical synthesis. They also offer intermediates crucial for pharmaceuticals and agrochemicals, alongside solvents and cleaning agents. For the electronics industry, the firm offers electronic materials, components for rechargeable batteries, and toners, all essential for manufacturing semiconductors, etching gases, and battery production. Its specialty plastics range includes cyclo olefin polymers (COP) and sophisticated products derived from COP, which are employed in optical lenses, medical apparatus, and a variety of common engineering plastics. Beyond materials, Zeon is involved in the development, manufacturing, and sales of medical devices for cardiovascular and gastrointestinal health, in addition to nutritional supplements. The company also engages in technology transfer, licensing its butadiene recovery and butene purification processes to around 23 countries globally. A notable product offering is PENTAM, an energy- and resource-efficient molded item.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.86% | +16.14% | +25.61% | +14.03% | +33.78% | +24.68% | +57.63% | +51.91% | +34.57% | +184.36% | +449.39% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 3 | +1 |
| Hold | 4 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-2.1% Q1'26: -2.8% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+46.5% ★ Q1'26: +35.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+12.2% ★ Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+8.4% Q1'26: +8.0% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+7.0% ★ Q1'26: +8.3% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-5.6% ★ Q1'26: -3.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.31× ★ Q1'26: 0.31× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 9 Rev. Ana. 9 EPS Ana. |
Mar 2027 9 Rev. Ana. 9 EPS Ana. |
Mar 2028 8 Rev. Ana. 8 EPS Ana. |
Mar 2029 2 Rev. Ana. 2 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
307.52B
est: 310.00B (-0.8%)
|
295.65B
est: 295.63B (+0.0%)
|
287.62B
est: 280.60B (+2.5%)
|
332.68B
est: 333.60B (-0.3%)
|
337.50B
est: 336.52B (+0.3%)
|
321.97B
est: 317.46B (+1.4%)
|
301.96B
est: 303.50B (-0.5%)
|
361.73B
est: 360.61B (+0.3%)
|
388.61B
est: 386.18B (+0.6%)
|
382.28B
est: 396.46B (-3.6%)
|
420.65B
est: 417.88B (+0.7%)
|
410.00B
399.26B – 422.93B
-1.9% YoY
|
424.49B
401.55B – 470.93B
+3.5% YoY
|
432.34B
431.79B – 432.89B
+1.9% YoY
|
411.50B
399.38B – 423.63B
-4.8% YoY
|
419.90B
397.21B – 465.84B
+2.0% YoY
|
| EBITDA |
50.62B
est: 45.89B (+10.3%)
|
48.46B
est: 43.76B (+10.7%)
|
52.48B
est: 41.54B (+26.4%)
|
46.39B
est: 49.38B (-6.1%)
|
46.06B
est: 49.81B (-7.5%)
|
45.07B
est: 46.99B (-4.1%)
|
56.45B
est: 44.93B (+25.6%)
|
67.83B
est: 53.38B (+27.1%)
|
34.93B
est: 57.17B (-38.9%)
|
64.04B
est: 60.00B (+6.7%)
|
52.51B
est: 63.24B (-17.0%)
|
62.05B
60.42B – 64.00B
-1.9% YoY
|
64.24B
60.77B – 71.27B
+3.5% YoY
|
65.43B
65.35B – 65.51B
+1.9% YoY
|
62.28B
60.44B – 64.11B
-4.8% YoY
|
63.55B
60.11B – 70.50B
+2.0% YoY
|
| EBIT |
30.51B
est: 29.10B (+4.9%)
|
26.88B
est: 27.75B (-3.1%)
|
31.38B
est: 26.34B (+19.1%)
|
25.18B
est: 31.32B (-19.6%)
|
27.24B
est: 31.59B (-13.8%)
|
27.62B
est: 29.80B (-7.3%)
|
38.30B
est: 28.49B (+34.4%)
|
46.36B
est: 33.85B (+36.9%)
|
14.55B
est: 36.25B (-59.9%)
|
43.92B
est: 38.53B (+14.0%)
|
33.07B
est: 40.61B (-18.6%)
|
39.85B
38.80B – 41.10B
-1.9% YoY
|
41.25B
39.02B – 45.77B
+3.5% YoY
|
42.02B
41.96B – 42.07B
+1.9% YoY
|
39.99B
38.81B – 41.17B
-4.8% YoY
|
40.81B
38.60B – 45.27B
+2.0% YoY
|
| Net Income |
19.08B
est: 17.35B (+10.0%)
|
18.08B
est: 16.41B (+10.2%)
|
23.15B
est: 19.13B (+21.0%)
|
13.06B
est: 15.64B (-16.5%)
|
18.46B
est: 19.25B (-4.1%)
|
20.20B
est: 17.89B (+12.9%)
|
27.72B
est: 21.98B (+26.1%)
|
33.41B
est: 32.89B (+1.6%)
|
10.57B
est: 19.03B (-44.5%)
|
31.10B
est: 33.46B (-7.0%)
|
26.20B
est: 25.52B (+2.7%)
|
29.99B
25.30B – 34.97B
+17.5% YoY
|
29.23B
27.68B – 38.72B
-2.5% YoY
|
31.51B
30.40B – 42.92B
+7.8% YoY
|
30.05B
26.59B – 33.68B
-4.6% YoY
|
31.06B
28.88B – 35.48B
+3.4% YoY
|
| SGA |
40.76B
est: 54.42B (-25.1%)
|
43.18B
est: 51.90B (-16.8%)
|
42.93B
est: 49.26B (-12.9%)
|
47.29B
est: 58.57B (-19.3%)
|
47.12B
est: 59.08B (-20.2%)
|
50.53B
est: 55.73B (-9.3%)
|
49.89B
est: 53.28B (-6.4%)
|
60.06B
est: 63.31B (-5.1%)
|
64.88B
est: 67.80B (-4.3%)
|
63.78B
est: 66.17B (-3.6%)
|
71.27B
est: 69.74B (+2.2%)
|
68.43B
66.63B – 70.58B
-1.9% YoY
|
70.84B
67.02B – 78.59B
+3.5% YoY
|
72.15B
72.06B – 72.25B
+1.9% YoY
|
68.68B
66.65B – 70.70B
-4.8% YoY
|
70.08B
66.29B – 77.74B
+2.0% YoY
|
| EPS |
84.13
est: 84.34 (-0.3%)
|
79.86
est: 79.78 (+0.1%)
|
104.31
est: 93.01 (+12.2%)
|
58.81
est: 76.04 (-22.7%)
|
84.06
est: 93.59 (-10.2%)
|
92.44
est: 86.96 (+6.3%)
|
126.74
est: 106.84 (+18.6%)
|
153.23
est: 159.92 (-4.2%)
|
49.94
est: 92.52 (-46.0%)
|
147.19
est: 158.34 (-7.0%)
|
127.43
est: 124.23 (+2.6%)
|
155.80
122.98 – 170.01
+25.4% YoY
|
156.96
134.55 – 188.23
+0.7% YoY
|
175.17
147.77 – 208.67
+11.6% YoY
|
146.50
129.25 – 163.75
-16.4% YoY
|
151.00
140.39 – 172.48
+3.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-11 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-01 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | UBS S&P Dividend Aristocrats ESG Elite UCITS ETF USD dis UBUM.DE | 1.04% | 2.15M | 0.30% |
| 2 | State Street SPDR S&P Global Dividend ETF WDIV | 0.92% | 2.46M | 0.40% |
| 3 | Cambria Foreign Shareholder Yield ETF FYLD | 0.91% | 6.03M | 0.59% |
| 4 | State Street SPDR S&P Global Dividend Aristocrats Screened UCITS ETF (Dist) GEDV.L | 0.70% | 168.9K | 0.45% |
| 5 | WisdomTree Japan SmallCap Dividend Fund DFJ | 0.50% | 1.91M | 0.58% |
| 6 | WisdomTree Dynamic International SmallCap Equity ETF DDLS | 0.19% | 825.8K | 0.48% |
| 7 | WisdomTree International SmallCap Dividend Fund DLS | 0.18% | 1.87M | 0.58% |
| 8 | Avantis International Small Cap Value ETF AVDV | 0.18% | 33.92M | 0.36% |
| 9 | FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund TLTD | 0.14% | 941.4K | 0.41% |
| 10 | iShares MSCI Japan Small Cap UCITS ETF IDJP.L | 0.14% | 765.2K | 0.58% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Tetsuya Toyoshima | President, Chief Executive Officer & Representative Director | 72M | — |
| Kimiaki Tanaka | Executive Chairman | 66M | male |
| Masayuki Shirakawa | President of Zeon Advanced Polymix Co., Ltd. | — | — |
| Noboru Watanabe | President of Zeon (Shanghai) Co., Ltd. & Zeon Trading (Shanghai) Co., Ltd. | — | — |
| Tomohiro Fukagata | Corporate Officer & Division Manager of Human Resources | — | — |
| Yoshiyuki Sone | Director & Senior Corporate Officer for Special Assignment | — | — |
| Kazuo Nakajima | Division Manager of Legal Affairs & Compliance | — | — |
| Yuichiro Konishi | Director, Senior Corporate Officer & Chief Technology Officer | — | — |
| Kazuyoshi Matsuura | Senior Corporate Officer, CFO & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4205.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
